Abstract:A cluster of single nucleotide polymorphisms (SNPs) in the first intron of the fat mass and obesity related (FTO) gene were the first common variants discovered to be associated with body mass index and body fatness. This review summarises what has been later discovered about the biology of FTO drawing together information from both human and animal studies. Subsequent work showed that the ‘at risk’ alleles of these SNPs are associated with greater food intake and increased hunger/lowered satiety, but are not associated with altered resting energy expenditure or low physical activity in humans. FTO is an FE (II) and 2-oxoglutarate dependent DNA/RNA methylase. Contrasting the impact of the SNPs on energy balance in humans, knocking out or reducing activity of the Fto gene in the mouse resulted in lowered adiposity, elevated energy expenditure with no impact on food intake (but the impact on expenditure is disputed). In contrast, overexpression of the gene in mice led to elevated food intake and adiposity, with no impact on expenditure. In rodents, the Fto gene is widely expressed in the brain including hypothalamic nuclei linked to food intake regulation. Since its activity is 2-oxoglutarate dependent it could potentially act as a sensor of citrate acid cycle flux, but this function has been dismissed, and instead it has been suggested to be much more likely to act as an amino acid sensor, linking circulating AAs to the mammalian target of rapamycin complex 1. This may be fundamental to its role in development but the link to obesity is less clear. It has been recently suggested that although the obesity related SNPs reside in the first intron of FTO, they may not only impact FTO but mediate their obesity effects via nearby genes (notably RPGRIP1L and IRX3).

Involvement of Leptin Receptor Long Isoform (Leprb)-Stat3 Signaling Pathway in Brain Fat Mass- and Obesity-Associated (FTO) Downregulation During Energy Restriction

FTO gene polymorphisms and obesity risk in Chinese population: a meta-analysis

Studies on the fat mass and obesity-associated (FTO) gene and its impact on obesity-associated diseases

FTO is a Transcriptional Repressor to Auto-Regulate Its Own Gene and Potentially Associated with Homeostasis of Body Weight.

Hepatokine Fetuin B expression is regulated by leptin-STAT3 signalling and associated with leptin in obesity

FTO inhibits UPRmt-induced apoptosis by activating JAK2/STAT3 pathway and reducing m6A level in adipocytes

Leptin signaling and leptin resistance.

Aberrant elevation of FTO levels promotes liver steatosis by decreasing the m<SUP>6</SUP>A methylation and increasing the stability of SREBF1 and ChREBP mRNAs

A link between FTO, ghrelin, and impaired brain food-cue responsivity

Aberrant elevation of FTO levels promotes liver steatosis by decreasing the m6A methylation and increasing the stability of SREBF1 and ChREBP mRNAs

The Fat Mass and Obesity Associated Gene Fto Functions in the Brain to Regulate Postnatal Growth in Mice

CCAAT/enhancer-binding Protein Α is a Crucial Regulator of Human Fat Mass and Obesity Associated Gene Transcription and Expression.

Lztfl1/BBS17 Controls Energy Homeostasis by Regulating the Leptin Signaling in the Hypothalamic Neurons.

Leptin Signaling is Required for Leucine Deprivation-enhanced Energy Expenditure*

FTO downregulation mediated by hypoxia facilitates colorectal cancer metastasis

TCF7L2 and Wnt Signalling Positively Regulate Leptin Gene Expression in Adipocytes

The ‘Fat Mass and Obesity Related’ (FTO) gene: Mechanisms of Impact on Obesity and Energy Balance

trans-Palmitoleic acid promotes adipose thermogenesis to reduce obesity via hypothalamic FFAR1 signaling

The Effect and Mechanism of TLR9/KLF4 in FFA-Induced Adipocyte Inflammation

Fat Mass and Obesity–Associated Protein Promotes Liver Steatosis by Targeting PPARα

A leptin-BDNF pathway regulating sympathetic innervation of adipose tissue